Autres langues DMK Pharmaceuticals Corporation

Actions

DMKPQ

US00547W3079

Marché Fermé - OTC Markets Autres places de cotation 21:53:07 26/04/2024			Varia. 5j.	Varia. 1 janv.
0,035 ^USD	-2,78 %		-30,42 %	-95,00 %

06/02	Motion d'administration conjointe approuvée pour DMK Pharmaceuticals Corporation	CI
02/02	Demande d'administration conjointe déposée par DMK Pharmaceuticals Corporation	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge	11/04
North American Morning Briefing : Focus Turns to -2-	04/04
Bidding Procedure Approved for DMK Pharmaceuticals Corporation	04/04
Motion for Asset Sale Filed by DMK Pharmaceuticals Corporation	21/03
DMK Pharmaceuticals Corporation(NasdaqCM:DMK) dropped from S&P TMI Index	08/02
Motion for Joint Administration Approved for DMK Pharmaceuticals Corporation	06/02
DMK Pharmaceuticals Corporation(OTCPK:DMKP.Q) dropped from NASDAQ Composite Index	06/02
DMK Pharmaceuticals Commences Restructuring Proceeding	03/02
Motion for Joint Administration Filed by DMK Pharmaceuticals Corporation	02/02
DMK Pharmaceuticals Corporation Filed for Bankruptcy	02/02
DMK Pharmaceuticals Corporation Announces Board Appointments	31/01
DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI	21/12
DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI® and Provides Corporate Update	28/11
DMK Pharmaceuticals Corporation Regains Full Rights from US WorldMeds for SYMJEPI	28/11
DMK Pharmaceuticals Corporation(OTCPK:DMKP.Q) added to NASDAQ Composite Index	21/11
Adamis Pharmaceuticals Corporation(NasdaqCM:ADMP) dropped from NASDAQ Composite Index	20/11
DMK Pharmaceuticals: Q3 Earnings Snapshot	14/11
Earnings Flash (DMK) DMK PHARMACEUTICALS CORPORATION Reports Q3 Revenue $9,062	14/11
DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update	14/11
DMK Pharmaceuticals Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues DMK Pharmaceuticals Corporation

Actions

DMKPQ

US00547W3079

Autres langues

Filtres